RUS  ENG
Full version
JOURNALS // Uspekhi Khimii // Archive

Usp. Khim., 2018 Volume 87, Issue 6, Pages 509–552 (Mi rcr4211)

This article is cited in 13 papers

Arbidol: a quarter-century later. Past, present and future of the original Russian antiviral

Konstantin V. Balakinab, Rosanna Filosacde, Sergey N. Lavrenovf, Arthur S. Mkrtchyang, Maxim B. Nawrozkijg, Ivan A. Novakovg

a Kazan (Volga Region) Federal University
b I. M. Sechenov First Moscow State Medical University
c Department of Experimental Medicine, Section of Biotechnology, University of Campania "Luigi Vanvitelli", Italy
d Consorzio Sannio Tech, Italy
e Institute of Food Sciences, National Research Council, Italy
f Gause Institute of New Antibiotics, Moscow
g Volgograd State Technical University

Abstract: The present review relates to the synthesis and structure-activity relationship studies of Arbidol and its structural analogues. The latter are roughly divided into several unequal parts: indole- and benzofuran-based compounds, benzimidazole and imidazopyridine bioisosteres, and ring-expanded quinoline derivatives. Much attention is focused on various types of antiviral activity of the above-mentioned Arbidol congeners, as well as of the parent compound itself. Features of Arbidol synthesis and metabolic changes are also discussed.
Bibliography — 166 references.

Received: 18.10.2017

Language: English

DOI: 10.1070/RCR4791


 English version:
Russian Chemical Reviews, 2018, 87:6, 509–552

Bibliographic databases:


© Steklov Math. Inst. of RAS, 2024